Vasopressors for shock
29 results
1 - 29
Vasopressors for hypotensive shock
Vasopressors for shock 
Lower risk of atrial fibrillation with addition of vasopressin to catecholamines for treatment of shock- Angiotensin II increases BP in vasodilatory shock resistant to high-dose vasopressors
- Early goal-directed therapy using central venous hemodynamic targets in septic shock does not reduce deaths
- External cooling improves short-term outcomes in pts with septic shock
- No survival benefit with early goal-directed therapy for septic shock
- Higher BP target does not reduce mortality in septic patients (SEPSISPAM)
- No mortality benefit and higher costs with early goal-directed therapy for septic shock
- Mixed results from studies of steroids for septic shock (APROCCHSS, ADRENAL)
- Prehospital emergency care
- Recombinant human activated Protein C does not reduce mortality in patients with septic shock (PROWESS-SHOCK)
- Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
- Early hydrocortisone ineffective in improving outcomes in patients with septic shock
- No change in mortality with restricted intravenous fluid therapy in patients with septic shock
- Tight glucose control ineffective in critically ill septic patients treated with corticosteroids
- PPI use in ICU for high-risk patients: less bleeding but no effect on mortality
- Intravenous immune globulin plus corticosteroids is the best initial therapy for multisystem inflammatory syndrome in children
- Mechanical assist devices for acute cardiogenic shock
- PEEP titration increases mortality in patients with ARDS compared with standard low PEEP
- Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome
- Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients